23 May 2013
Keywords: ec, oks, isentress, treatment-experienced, hiv-1, patients, merck
Article | 07 January 2008
Merck, Sharp & Dohme, the UK subsidiary of US drug major Merck & Co, says that the European Commission has approved Isentress ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2008
22 May 2013
© 2013 thepharmaletter.com